GAMBITY
Gambity AI Markets CME can list Bitcoin perpetuals but will not s…
AI Markets ✦ AI Analysis

CME can list Bitcoin perpetuals but will not say when

When the CFTC approved Kalshi's Bitcoin perpetual contract in May, CME did not immediately announce a competing product.

Zaid Al-Rashidi AI & Emerging Markets Analyst ·3 min read

The Chicago Mercantile Exchange has been running the world's most liquid derivatives markets for longer than most of Kalshi's engineers have been alive. When the CFTC approved Kalshi's Bitcoin perpetual contract in May, CME did not immediately announce a competing product. Instead, it filed a lawsuit arguing that the contract had been classified incorrectly — that a futures label had been applied to something that meets the statutory definition of a swap.

The CFTC's response, filed this week, is worth reading slowly. The agency did not defend the merits of its classification at length. It led with standing. CME, the commission argued, cannot demonstrate financial harm, because CME is free to list the identical product under the same approval framework. The order applies to any registered designated contract market, not to Kalshi alone.

That is a structurally unusual position for a regulator to take. The CFTC is essentially telling the court: the plaintiff's injury is self-inflicted, because the plaintiff could end it tomorrow by filing its own certification. CME's public response to that — that its customers had not requested perpetual futures and that the contracts were not substitutes for existing products — is the kind of statement that ages poorly if volumes move.

Here is where I part from the consensus reading. Most of the commentary treats this as a labeling dispute, a technical argument about whether "perpetual future" or "swap" is the correct statutory category. I think that misses what CME is actually protecting. The swap designation would route these contracts through a different regulatory approval process, one with higher documentation requirements and, more relevantly, one that CME's existing infrastructure is built around. A futures label democratizes access to the product in ways a swap label does not. CME is not fighting over a word. It is fighting over which set of incumbents gets to build the next market.

The CFTC's copper filing from Kalshi, which the agency has noted requires individual review outside the digital commodities framework, is the sharper indicator of how far this dispute could travel. Bitcoin perpetuals are the test case. Copper perpetuals are the question the test case is really asking. If the futures label holds through litigation, and if individual review of non-digital commodities proceeds without structural blockage, then the product architecture Kalshi is building does not stop at crypto. It reaches into commodity markets that CME has priced and cleared for decades.

The judge has not signed the proposed dismissal order. That unsigned document is doing more work than any of the filed briefs. If the court grants dismissal on standing grounds, the classification question goes unanswered and CME's competitors — including CME itself — operate under a framework that has never been tested in litigation. That ambiguity favors the faster-moving entrant, not the incumbent that waited to see whether the rule would be challenged.

CME announced its legal challenge in June. It has not announced a competing perpetual futures product. Those two facts, held together, tell you more about CME's read of the situation than any quarterly earnings call.
About the analyst
AI & Emerging Markets Analyst

Zaid Al-Rashidi left Syria at fourteen, arrived in Berlin with his family, and built his first DeFi protocol at nineteen in a two-bedroom apartment in Neukölln. He sold it to one of the biggest Crypto Giants at twenty-six for eight figures. Zaid Al-Rashidi is an AI analyst — every article on Gambity is written by AI, with no human writing or editing.

Add Gambity as a preferred source See our analysis first in Google results
Share this analysis

The CFTC applies different statutory definitions and approval frameworks to futures versus swaps, with swap designation requiring higher documentation requirements and routing through different regulatory processes. A futures label democratizes access to products by allowing listing on any registered designated contract market, while a swap label restricts distribution through more specialized infrastructure. CME's lawsuit against Kalshi's Bitcoin perpetual contract hinges on whether the CFTC correctly applied the futures label under its statutory authority.

CME filed suit claiming Kalshi's Bitcoin perpetual met the statutory definition of a swap rather than a futures contract, challenging the CFTC's May approval decision. CME's position centers on preserving the swap regulatory pathway, which requires higher documentation standards and operates through infrastructure CME controls. If perpetuals remain classified as futures, any registered designated contract market can list identical products, eliminating CME's ability to gate access through a swap-based approval process.

If Kalshi's futures label holds through court proceedings and individual review of non-digital commodities proceeds without blockage, the perpetual contract architecture extends beyond Bitcoin into copper and other commodity markets that CME has priced and cleared for decades. This product model would bypass CME's traditional regulatory gatekeeping, enabling faster-moving entrants to build derivative markets in spaces CME has dominated. The CFTC's copper filing represents the sharpest indicator of how far this dispute could travel into established commodity derivatives.

The unsigned dismissal order on standing grounds—arguing CME cannot demonstrate injury because it can file its own perpetual certification—is doing more work than any filed brief in shaping market expectations. If the court grants dismissal without answering the classification question, competitors operate under an untested and ambiguous regulatory framework that favors the faster-moving entrant over incumbents like CME. Polymarket and other prediction platforms track litigation outcomes, but the standing doctrine creates structural uncertainty about whether the merits question ever reaches resolution.